Trends in Spending on Selective Beta2 Agonists in General Practice in England

1
Trends in Spending on Selective Beta2 Agonists
in General Practice in England
2
Trends in Usage of Selective Beta2 Agonists in
General Practice in England
3
Trends in Spending on Short-acting Selective
Beta2 Agonists in General Practice in England
4
Trends in Usage of Short-acting Selective Beta2
Agonists in General Practice in England
5
Trends in Spending on Long-acting Selective Beta2
Agonists in General Practice in England
6
Trends in Usage of Long-acting Selective Beta2
Agonists in General Practice in England
7
Trends in Spending on Selective Beta2 Agonists
(by Device) in General Practice in England
8
Trends in Usage of Selective Beta2 Agonists (by
Device) in General Practice in England
9
Trends in Spending on Antimuscarinic
Bronchodilators Including Combinations in
General Practice in England
10
Trends in Usage of Antimuscarinic Bronchodilators
Including Combinations in General Practice in
England
11
Trends in Spending on Theophylline and
Aminophyllinein General Practice in England
12
Trends in Usage of Theophylline and
Aminophylline in General Practice in England
13
Trends in Spending on Inhaled Corticosteroids
(excluding Combinations) in General Practice in
England
14
Trends in Usage of Inhaled Corticosteroids
(excluding Combinations) in General Practice in
England
15
Trends in Spending on Inhaled Corticosteroids (by
Device) in General Practice in England
16
Trends in Usage of Inhaled Corticosteroids (by
Device) in General Practice in England
17
Trends in Spending on Seretide and Symbicortin
General Practice in England
18
Trends in Usage of Seretide and Symbicortin
General Practice in England
19
Trends in Prescribing of Seretide Inhaler by
Strengthin General Practice in England
20
Trends in Spending on Seretide Inhaler by
Strengthin General Practice in England
21
Trends in Prescribing of Leukotriene Receptor
Antagonists in General Practice in England
22
Trends in Spending on Leukotriene Receptor
Antagonists in General Practice in England
23
Trends in Prescribing of Non-Sedating
Antihistamines in General Practice in England
24
Trends in Spending on Non-Sedating Antihistamines
in General Practice in England
25
Trends in Prescribing of Sedating Antihistamines
in General Practice in England
26
Trends in Spending on Sedating Antihistamines in
General Practice in England
27
Trends in Prescribing of Adrenaline (BNF 3.4.3
Allergic Emergencies) in General Practice in
England
28
Trends in Spending on Adrenaline (BNF 3.4.3
Allergic Emergencies) in General Practice in
England
29
Trends in Prescribing of Mucolytics (excluding
Dornase Alfa) in General Practice in England
30
Trends in Spending on Mucolytics (excluding
Dornase Alfa) in General Practice in England
31
Trends in Prescribing of and Spending on Nicotine
Replacement Therapy in General Practice in
England
32
Trends in Prescribing of Different Formulations
of Nicotine Replacement Therapy in General
Practice in England
33
Trends in Spending on Different Formulations of
Nicotine Replacement Therapy in General Practice
in England
34
Trends in Prescribing of and Spending on
Bupropion in General Practice in England
35
Trends in Prescribing of and Spending on
Varenicline in General Practice in England
36
Trends in Prescribing of NICE Drugs for
Influenzain General Practice in England
37
Trends in Spending on NICE Drugs for Influenzain
General Practice in England